A Study of the Active Site of Influenza Virus Sialidase: An Approach to the Rational Design of Novel Anti-influenza Drugs
Citations Over TimeTop 10% of 1996 papers
Abstract
The development of sialidase inhibitor-based potential anti-influenza drugs using rational drug design techniques has been of recent interest. The present study details an investigation of the active site of influenza virus sialidase by using the program GRID in an attempt to design more potent inhibitors in the hope they will eventually lead to anti-influenza drugs. A number of different probes (amino, carboxy, hydroxy, methyl, etc.) have been used in an effort to determine the functional groups most likely to improve the binding of the starting template 2-deoxy-2,3-didehydro-N-acetylneuraminic acid (Neu5Ac2en). The data have correctly predicted the binding regions for the carboxylate, acetamido (NH and methyl), and glycerol (OH) groups of N-acetylneuraminic acid. Moreover, the data suggest that the addition of certain functionalities (amino group) at the C-4 position should enhance the overall binding.
Related Papers
- → Evolutional analysis of human influenza A virus N2 neuraminidase genes based on the transition of the low‐pH stability of sialidase activity1(2003)20 cited
- → Polymorphonuclear leukocytic sialic acid and sialidase activity in obesity(1997)2 cited
- → Reappearance in vivo of neuraminidase-sensitive sialic acid in L 5222 rat leukemia cells(1976)4 cited
- → Blood plasma sialidase activity in CHD patients and healthy subjects is partially accounted for influenza virus neuraminidase(2020)
- → The presence of sialic acid in bovine serum amyloid P component (กรดไซอะลคในซรมโปรตน Amyloid P component ในโค)(1995)